Similar Clinical Outcomes of Early and Late Anti-TNF Initiation for Ulcerative Colitis: A Nationwide Population-Based Study
Open Access
- 1 January 2020
- journal article
- research article
- Published by XMLink in Yonsei Medical Journal
- Vol. 61 (5) , 382-390
Abstract
Han M, et al. Yonsei Med J. 2020 May;61(5):382-390. https://doi.org/10.3349/ymj.2020.61.5.382Keywords
This publication has 25 references indexed in Scilit:
- Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in AsiaIntestinal Research, 2019
- Immunological pathogenesis of inflammatory bowel diseaseIntestinal Research, 2018
- Anti-TNF Therapy Within 2 Years of Crohnʼs Disease Diagnosis Improves Patient OutcomesInflammatory Bowel Diseases, 2016
- Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2015
- Adalimumab Therapy Is Associated With Reduced Risk of Hospitalization in Patients With Ulcerative ColitisGastroenterology, 2014
- Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative ColitisGastroenterology, 2014
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative ColitisGastroenterology, 2014
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative ColitisGastroenterology, 2012
- Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or InfliximabGastroenterology, 2009
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005